APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loxapine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Loxapine Industry Growth and Trends Forecast to 2032

19 December 2025105 pages

Choose your research edition.

Industry ResearchLoxapine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Loxapine Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Loxapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loxapine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Loxapine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Loxapine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Loxapine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Loxapine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Loxapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Loxapine include Eisai, Teva, Novartis, Mylan Pharmaceuticals, Pfizer, Wyeth, Watson Laboratories, Swiss Pharmaceutical and Grupo Ferrer Internacional, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Loxapine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Loxapine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Loxapine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Loxapine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Loxapine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Loxapine Market by Company

Eisai

Teva

Novartis

Mylan Pharmaceuticals

Pfizer

Wyeth

Watson Laboratories

Swiss Pharmaceutical

Grupo Ferrer Internacional

Galen Pharmaceuticals

Delta Pharma

Bioprojet Pharma

Bago Pharmaceutical

AOP Orphan Pharmaceuticals

Loxapine Segment by Type

Powder

Tablet

Loxapine Segment by Application

Hospital

Drug Store

Loxapine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loxapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loxapine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loxapine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Loxapine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Loxapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Powder Table 2. Major Company of Tablet Table 3. Global Loxapine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Loxapine Sales by Type (2021-2026) & (K Units) Table 5. Global Loxapine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Loxapine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Loxapine Sales Market Share in Value by Type (2021-2026) Table 8. Global Loxapine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Loxapine Sales by Type (2027-2032) & (K Units) Table 10. Global Loxapine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Loxapine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Loxapine Sales Market Share in Value by Type (2027-2032) Table 13. Global Loxapine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Loxapine Sales by Type (2021-2026) & (K Units) Table 15. North America Loxapine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Loxapine Sales by Type (2021-2026) & (K Units) Table 17. Europe Loxapine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Loxapine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Loxapine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Loxapine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Loxapine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Loxapine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Loxapine Sales by Type (2021-2026) & (US$ Million) Table 24. Loxapine Industry Trends Table 25. Loxapine Industry Drivers Table 26. Loxapine Industry Opportunities and Challenges Table 27. Loxapine Industry Restraints Table 28. Global Loxapine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Loxapine Revenue Market Share by Company (2021-2026) Table 30. Global Loxapine Sales by Company (2021-2026) & (K Units) Table 31. Global Loxapine Sales Share by Company (2021-2026) Table 32. Global Loxapine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Loxapine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Loxapine Major Company Production Sites and Headquarters Table 35. Global Loxapine Company, Product Type & Application Table 36. Global Loxapine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Loxapine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Loxapine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Loxapine Sales by Region (2021-2026) & (K Units) Table 41. Global Loxapine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Loxapine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Loxapine Sales Market Share in Value by Region (2021-2026) Table 44. Global Loxapine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Loxapine Sales by Region (2027-2032) & (K Units) Table 46. Global Loxapine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Loxapine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Loxapine Sales Market Share in Value by Region (2027-2032) Table 49. Global Loxapine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Loxapine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Loxapine Sales by Application (2021-2026) & (K Units) Table 52. Global Loxapine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Loxapine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Loxapine Sales Market Share in Value by Application (2021-2026) Table 55. Global Loxapine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Loxapine Sales by Application (2027-2032) & (K Units) Table 57. Global Loxapine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Loxapine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Loxapine Sales Market Share in Value by Application (2027-2032) Table 60. Global Loxapine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Loxapine Sales by Application (2021-2026) & (K Units) Table 62. North America Loxapine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Loxapine Sales by Application (2021-2026) & (K Units) Table 64. Europe Loxapine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Loxapine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Loxapine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Loxapine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Loxapine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Loxapine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Loxapine Sales by Application (2021-2026) & (US$ Million) Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Eisai Loxapine Product Portfolio Table 75. Eisai Recent Development Table 76. Teva Company Information Table 77. Teva Business Overview Table 78. Teva Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Teva Loxapine Product Portfolio Table 80. Teva Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis Loxapine Product Portfolio Table 85. Novartis Recent Development Table 86. Mylan Pharmaceuticals Company Information Table 87. Mylan Pharmaceuticals Business Overview Table 88. Mylan Pharmaceuticals Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Mylan Pharmaceuticals Loxapine Product Portfolio Table 90. Mylan Pharmaceuticals Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pfizer Loxapine Product Portfolio Table 95. Pfizer Recent Development Table 96. Wyeth Company Information Table 97. Wyeth Business Overview Table 98. Wyeth Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Wyeth Loxapine Product Portfolio Table 100. Wyeth Recent Development Table 101. Watson Laboratories Company Information Table 102. Watson Laboratories Business Overview Table 103. Watson Laboratories Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Watson Laboratories Loxapine Product Portfolio Table 105. Watson Laboratories Recent Development Table 106. Swiss Pharmaceutical Company Information Table 107. Swiss Pharmaceutical Business Overview Table 108. Swiss Pharmaceutical Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Swiss Pharmaceutical Loxapine Product Portfolio Table 110. Swiss Pharmaceutical Recent Development Table 111. Grupo Ferrer Internacional Company Information Table 112. Grupo Ferrer Internacional Business Overview Table 113. Grupo Ferrer Internacional Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Grupo Ferrer Internacional Loxapine Product Portfolio Table 115. Grupo Ferrer Internacional Recent Development Table 116. Galen Pharmaceuticals Company Information Table 117. Galen Pharmaceuticals Business Overview Table 118. Galen Pharmaceuticals Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Galen Pharmaceuticals Loxapine Product Portfolio Table 120. Galen Pharmaceuticals Recent Development Table 121. Delta Pharma Company Information Table 122. Delta Pharma Business Overview Table 123. Delta Pharma Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Delta Pharma Loxapine Product Portfolio Table 125. Delta Pharma Recent Development Table 126. Bioprojet Pharma Company Information Table 127. Bioprojet Pharma Business Overview Table 128. Bioprojet Pharma Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Bioprojet Pharma Loxapine Product Portfolio Table 130. Bioprojet Pharma Recent Development Table 131. Bago Pharmaceutical Company Information Table 132. Bago Pharmaceutical Business Overview Table 133. Bago Pharmaceutical Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Bago Pharmaceutical Loxapine Product Portfolio Table 135. Bago Pharmaceutical Recent Development Table 136. AOP Orphan Pharmaceuticals Company Information Table 137. AOP Orphan Pharmaceuticals Business Overview Table 138. AOP Orphan Pharmaceuticals Loxapine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. AOP Orphan Pharmaceuticals Loxapine Product Portfolio Table 140. AOP Orphan Pharmaceuticals Recent Development Table 141. North America Loxapine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Loxapine Sales by Country (2021-2026) & (K Units) Table 143. North America Loxapine Sales Market Share by Country (2021-2026) Table 144. North America Loxapine Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Loxapine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Loxapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Loxapine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Loxapine Market Share by Country (2021-2026) Table 149. North America Loxapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Loxapine Market Share Forecast by Country (2027-2032) Table 151. Europe Loxapine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Loxapine Sales by Country (2021-2026) & (K Units) Table 153. Europe Loxapine Sales Market Share by Country (2021-2026) Table 154. Europe Loxapine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Loxapine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Loxapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Loxapine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Loxapine Market Share by Country (2021-2026) Table 159. Europe Loxapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Loxapine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Loxapine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Loxapine Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Loxapine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Loxapine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Loxapine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Loxapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Loxapine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Loxapine Market Share by Country (2021-2026) Table 169. Asia-Pacific Loxapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Loxapine Market Share Forecast by Country (2027-2032) Table 171. Latin America Loxapine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Loxapine Sales by Country (2021-2026) & (K Units) Table 173. Latin America Loxapine Sales Market Share by Country (2021-2026) Table 174. Latin America Loxapine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Loxapine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Loxapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Loxapine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Loxapine Market Share by Country (2021-2026) Table 179. Latin America Loxapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Loxapine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Loxapine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Loxapine Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Loxapine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Loxapine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Loxapine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Loxapine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Loxapine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Loxapine Market Share by Country (2021-2026) Table 189. Middle East and Africa Loxapine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Loxapine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Loxapine Distributors List Table 194. Loxapine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Loxapine Image Figure 2. Global Loxapine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loxapine Market Size (2021-2032) & (US$ Million) Figure 4. Global Loxapine Sales (2021-2032) & (K Units) Figure 5. Powder Image Figure 6. Global Powder Sales YoY Growth (2021-2032) & (K Units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Loxapine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Loxapine Market Share by Type 2025 VS 2032 Figure 11. North America Loxapine Sales Market Share in Volume by Type in 2025 Figure 12. North America Loxapine Sales Market Share in Value by Type in 2025 Figure 13. Europe Loxapine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Loxapine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Loxapine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Loxapine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Loxapine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Loxapine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Loxapine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Loxapine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Loxapine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drug Store Image Figure 26. Global Drug Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Loxapine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Loxapine Market Share by Application 2025 VS 2032 Figure 29. North America Loxapine Sales Market Share in Volume by Application in 2025 Figure 30. North America Loxapine Sales Market Share in Value by Application in 2025 Figure 31. Europe Loxapine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Loxapine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Loxapine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Loxapine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Loxapine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Loxapine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Loxapine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Loxapine Sales Market Share in Value by Application in 2025 Figure 39. North America Loxapine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Loxapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Loxapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Loxapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Loxapine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Loxapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Loxapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Loxapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Loxapine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Loxapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Loxapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Loxapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Loxapine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Loxapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Loxapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Loxapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Loxapine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Loxapine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Loxapine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Loxapine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Loxapine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Loxapine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Tablet
Applications
  • Hospital
  • Drug Store
Companies covered
  • Eisai
  • Teva
  • Novartis
  • Mylan Pharmaceuticals
  • Pfizer
  • Wyeth
  • Watson Laboratories
  • Swiss Pharmaceutical
  • Grupo Ferrer Internacional
  • Galen Pharmaceuticals
  • Delta Pharma
  • Bioprojet Pharma
  • Bago Pharmaceutical
  • AOP Orphan Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loxapine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Loxapine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Loxapine Market by Type
  6. 1.3.1 Powder
  7. 1.3.2 Tablet
  8. 1.4 Global Loxapine Market Size by Type
  9. 1.4.1 Global Loxapine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Loxapine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Loxapine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Loxapine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Loxapine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Loxapine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Loxapine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Loxapine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Loxapine Industry Trends
  2. 2.2 Loxapine Industry Drivers
  3. 2.3 Loxapine Industry Opportunities and Challenges
  4. 2.4 Loxapine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Loxapine Revenue (2021-2026)
  2. 3.2 Global Top Players by Loxapine Sales (2021-2026)
  3. 3.3 Global Top Players by Loxapine Price (2021-2026)
  4. 3.4 Global Loxapine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Loxapine Major Company Production Sites & Headquarters
  6. 3.6 Global Loxapine Company, Product Type & Application
  7. 3.7 Global Loxapine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Loxapine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Loxapine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Loxapine Tier 1, Tier 2, and Tier 3
4 Loxapine Regional Status and Outlook
  1. 4.1 Global Loxapine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Loxapine Historic Market Size by Region
  3. 4.2.1 Global Loxapine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Loxapine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Loxapine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Loxapine Forecasted Market Size by Region
  7. 4.3.1 Global Loxapine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Loxapine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Loxapine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Loxapine by Application
  1. 5.1 Loxapine Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Loxapine Market Size by Application
  5. 5.2.1 Global Loxapine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Loxapine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Loxapine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Loxapine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Loxapine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Loxapine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Loxapine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Loxapine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Loxapine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Loxapine Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Loxapine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Loxapine Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Loxapine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Loxapine Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Mylan Pharmaceuticals
  20. 6.4.1 Mylan Pharmaceuticals Company Information
  21. 6.4.2 Mylan Pharmaceuticals Business Overview
  22. 6.4.3 Mylan Pharmaceuticals Loxapine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Pharmaceuticals Loxapine Product Portfolio
  24. 6.4.5 Mylan Pharmaceuticals Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Loxapine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Loxapine Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Wyeth
  32. 6.6.1 Wyeth Company Information
  33. 6.6.2 Wyeth Business Overview
  34. 6.6.3 Wyeth Loxapine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Wyeth Loxapine Product Portfolio
  36. 6.6.5 Wyeth Recent Developments
  37. 6.7 Watson Laboratories
  38. 6.7.1 Watson Laboratories Company Information
  39. 6.7.2 Watson Laboratories Business Overview
  40. 6.7.3 Watson Laboratories Loxapine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Watson Laboratories Loxapine Product Portfolio
  42. 6.7.5 Watson Laboratories Recent Developments
  43. 6.8 Swiss Pharmaceutical
  44. 6.8.1 Swiss Pharmaceutical Company Information
  45. 6.8.2 Swiss Pharmaceutical Business Overview
  46. 6.8.3 Swiss Pharmaceutical Loxapine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Swiss Pharmaceutical Loxapine Product Portfolio
  48. 6.8.5 Swiss Pharmaceutical Recent Developments
  49. 6.9 Grupo Ferrer Internacional
  50. 6.9.1 Grupo Ferrer Internacional Company Information
  51. 6.9.2 Grupo Ferrer Internacional Business Overview
  52. 6.9.3 Grupo Ferrer Internacional Loxapine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Grupo Ferrer Internacional Loxapine Product Portfolio
  54. 6.9.5 Grupo Ferrer Internacional Recent Developments
  55. 6.10 Galen Pharmaceuticals
  56. 6.10.1 Galen Pharmaceuticals Company Information
  57. 6.10.2 Galen Pharmaceuticals Business Overview
  58. 6.10.3 Galen Pharmaceuticals Loxapine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Galen Pharmaceuticals Loxapine Product Portfolio
  60. 6.10.5 Galen Pharmaceuticals Recent Developments
  61. 6.11 Delta Pharma
  62. 6.11.1 Delta Pharma Company Information
  63. 6.11.2 Delta Pharma Business Overview
  64. 6.11.3 Delta Pharma Loxapine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Delta Pharma Loxapine Product Portfolio
  66. 6.11.5 Delta Pharma Recent Developments
  67. 6.12 Bioprojet Pharma
  68. 6.12.1 Bioprojet Pharma Company Information
  69. 6.12.2 Bioprojet Pharma Business Overview
  70. 6.12.3 Bioprojet Pharma Loxapine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Bioprojet Pharma Loxapine Product Portfolio
  72. 6.12.5 Bioprojet Pharma Recent Developments
  73. 6.13 Bago Pharmaceutical
  74. 6.13.1 Bago Pharmaceutical Company Information
  75. 6.13.2 Bago Pharmaceutical Business Overview
  76. 6.13.3 Bago Pharmaceutical Loxapine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bago Pharmaceutical Loxapine Product Portfolio
  78. 6.13.5 Bago Pharmaceutical Recent Developments
  79. 6.14 AOP Orphan Pharmaceuticals
  80. 6.14.1 AOP Orphan Pharmaceuticals Company Information
  81. 6.14.2 AOP Orphan Pharmaceuticals Business Overview
  82. 6.14.3 AOP Orphan Pharmaceuticals Loxapine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 AOP Orphan Pharmaceuticals Loxapine Product Portfolio
  84. 6.14.5 AOP Orphan Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Loxapine Sales by Country
  2. 7.1.1 North America Loxapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Loxapine Sales by Country (2021-2026)
  4. 7.1.3 North America Loxapine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Loxapine Market Size by Country
  6. 7.2.1 North America Loxapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Loxapine Market Size by Country (2021-2026)
  8. 7.2.3 North America Loxapine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Loxapine Sales by Country
  2. 8.1.1 Europe Loxapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Loxapine Sales by Country (2021-2026)
  4. 8.1.3 Europe Loxapine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Loxapine Market Size by Country
  6. 8.2.1 Europe Loxapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Loxapine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Loxapine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Loxapine Sales by Country
  2. 9.1.1 Asia-Pacific Loxapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Loxapine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Loxapine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Loxapine Market Size by Country
  6. 9.2.1 Asia-Pacific Loxapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Loxapine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Loxapine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Loxapine Sales by Country
  2. 10.1.1 South America Loxapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Loxapine Sales by Country (2021-2026)
  4. 10.1.3 South America Loxapine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Loxapine Market Size by Country
  6. 10.2.1 South America Loxapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Loxapine Market Size by Country (2021-2026)
  8. 10.2.3 South America Loxapine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Loxapine Sales by Country
  2. 11.1.1 Middle East and Africa Loxapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Loxapine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Loxapine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Loxapine Market Size by Country
  6. 11.2.1 Middle East and Africa Loxapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Loxapine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Loxapine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Loxapine Value Chain Analysis
  2. 12.1.1 Loxapine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Loxapine Production Mode & Process
  7. 12.2 Loxapine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Loxapine Distributors
  10. 12.2.3 Loxapine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst